Evidence map›Paper›PMID 39108479›Full record

ArticleResearch square2024

Hemin-Induced Transient Senescence Via DNA Damage Response: A Neuroprotective Mechanism Against Ferroptosis in Intracerebral Hemorrhage.

Vikas H Maloji Rao, Velmarini Vasquez, Manohar Kodavati, Joy Mitra, Vincent Provasek, Anh Voh, Anton Liopo, Paul J Derry, Andrei Mikheve, Robert C Rostomily and 5 more

Abstract readPreprint
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Vikas H Maloji RaoDivision of DNA Repair Research within the, Department of Neurosurgery, Houston Methodist Research Institute, Houston, TX 77030, USA.
Velmarini VasquezDivision of DNA Repair Research within the, Department of Neurosurgery, Houston Methodist Research Institute, Houston, TX 77030, USA.
Manohar KodavatiDivision of DNA Repair Research within the, Department of Neurosurgery, Houston Methodist Research Institute, Houston, TX 77030, USA.ORCID 0000-0001-5827-6964
Joy MitraDivision of DNA Repair Research within the, Department of Neurosurgery, Houston Methodist Research Institute, Houston, TX 77030, USA.
Vincent ProvasekDivision of DNA Repair Research within the, Department of Neurosurgery, Houston Methodist Research Institute, Houston, TX 77030, USA.
Anh VohCenter for Genomics and Precision Medicine, Department of Translational Medical Sciences, Institute of Biosciences and Technology, College of Medicine, Texas A&M Health Science Center, Houston, TX 77030, USA.ORCID 0000-0001-8400-0291
Anton LiopoCenter for Genomics and Precision Medicine, Department of Translational Medical Sciences, Institute of Biosciences and Technology, College of Medicine, Texas A&M Health Science Center, Houston, TX 77030, USA.
Paul J DerryCenter for Genomics and Precision Medicine, Department of Translational Medical Sciences, Institute of Biosciences and Technology, College of Medicine, Texas A&M Health Science Center, Houston, TX 77030, USA.
Andrei MikheveCenter for Neuroregeneration, Department of Neurosurgery, Houston Methodist Research Institute, Houston, TX 77030, USA.
Robert C RostomilyCenter for Neuroregeneration, Department of Neurosurgery, Houston Methodist Research Institute, Houston, TX 77030, USA.
Philip J HornerCenter for Neuroregeneration, Department of Neurosurgery, Houston Methodist Research Institute, Houston, TX 77030, USA.
James M TourNanoCarbon Center and the Rice Institute for Advanced Materials, Department of Chemistry, Rice University, Houston, TX 77030, USA.ORCID 0000-0002-8479-9328
Gavin W BritzCenter for Neuroregeneration, Department of Neurosurgery, Houston Methodist Research Institute, Houston, TX 77030, USA.
Thomas A KentCenter for Genomics and Precision Medicine, Department of Translational Medical Sciences, Institute of Biosciences and Technology, College of Medicine, Texas A&M Health Science Center, Houston, TX 77030, USA.
Muralidhar HegdeDivision of DNA Repair Research within the, Department of Neurosurgery, Houston Methodist Research Institute, Houston, TX 77030, USA.ORCID 0000-0001-7333-8123

Funding

Novel Carbon Nanozyme Mechanisms for Traumatic Brain InjuryR01NS094535 · NINDS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI HEGDE, MURALIDHAR L, KENT, THOMAS · 2015 to 2024
$4.1M
Defining the altered FUS-PARP-1-DNA Ligase III axis and its implications to nuclear and mitochondrial genome damage response in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)RF1NS112719 · NINDS · METHODIST HOSPITAL RESEARCH INSTITUTE · PI HEGDE, MURALIDHAR L · 2020 to 2020
$2.0M
NINDS NIH HHS R01 NS094535NINDS NIH HHS RF1 NS112719
6 · The paper itself

Abstract

Intracerebral hemorrhage (ICH) poses acute fatality and long-term neurological risks due to hemin and iron accumulation from hemoglobin breakdown. Our observation that hemin induces DNA double-strand breaks (DSBs), prompting a senescence-like phenotype in neurons, necessitating deeper exploration of cellular responses. Using experimental ICH models and human ICH patient tissue, we elucidate hemin-mediated DNA damage response (DDR) inducing transient senescence and delayed expression of heme oxygenase (HO-1). HO-1 co-localizes with senescence-associated β-Galactosidase (SA-β-Gal) in ICH patient tissues, emphasizing clinical relevance of inducible HO-1 expression in senescent cells. We reveal a reversible senescence state protective against acute cell death by hemin, while repeat exposure leads to long-lasting senescence. Inhibiting early senescence expression increases cell death, supporting the protective role of senescence against hemin toxicity. Hemin-induced senescence is attenuated by a pleiotropic carbon nanoparticle that is a catalytic mimic of superoxide dismutase, but this treatment increased lipid peroxidation, consistent with ferroptosis from hemin breakdown released iron. When coupled with iron chelator deferoxamine (DEF), the nanoparticle reduces hemin-induced senescence and upregulates factors protecting against ferroptosis. Our study suggests transient senescence induced by DDR as an early potential neuroprotective mechanism in ICH, but the risk or iron-related toxicity supports a multi-pronged therapeutic approach.

Indexed as

Adaptive neuroprotectionDNA damage response (DDR)FerroptosisHeme oxygenase-1 (HO-1)HemorrhageSenescence

Identifiers

PMID39108479
PMCPMC11302695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.